Grant Beck, DPM
Foot & Ankle Surgery · Las Vegas, NVNPI 1649446220
Payments from drug & device makers
What this record shows
This record is dominated by education: $6,168 of the $9,580 with a category attached, or 64.4%. 20 manufacturers reported payments, led by Goode Surgical Inc at 40.2% of the total. Reporting peaked in 2019 at $6,327 and has fallen 85.6% since, to $914 in 2025.
Across 78 payments — averaging $122.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Goode Surgical Inc$4K
- Arthrex$4K
- Lifenet Health$1K
- Aroa Biosurgery Incorporated$254
- Smith+Nephew$248
- Boston Scientific$76
- plus $382 from 14 others
What the payments were for
- Travel & lodging$4645%
- Food & beverage$2,94731%
- Education$6,16864%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Goode Surgical Inc | 13 | $3,854 |
| Arthrex | 9 | $3,598 |
| Lifenet Health | 14 | $1,168 |
| Aroa Biosurgery Incorporated | 5 | $254 |
| Smith+Nephew | 12 | $248 |
| Boston Scientific | 4 | $76 |
| Bioventus LLC | 5 | $73 |
| Stryker | 3 | $62 |
| Linvatec Corporation | 2 | $53 |
| International Life Sciences | 1 | $31 |
| Ossio Inc | 1 | $26 |
| Melinta Therapeutics, LLC | 1 | $25 |
| ANI Pharmaceuticals, Inc. | 1 | $21 |
| Biocomposites Inc | 1 | $20 |
| Misonix Inc | 1 | $20 |
| Curonix LLC | 1 | $14 |
| KCI USA, Inc. | 1 | $12 |
| Medela LLC | 1 | $11 |
| Orthofix Medical, Inc. | 1 | $10 |
| Stimwave Technologies Incorporated | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,580 in reported general payments places this provider in the 75th percentile of 84 foot & ankle surgery providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 39 | $2,222 |
| Pregabalin | 154 | $1,700 |
| Gabapentin | 144 | $1,476 |
| Linezolid | 16 | $1,462 |
| Duloxetine Hcl | 46 | $694 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 29 | $684 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 106 | $658 |
| Colchicine | 34 | $540 |
| Doxycycline Hyclate | 94 | $417 |
| Lidocaine | 12 | $374 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 30 | $332 |
| Terbinafine Hcl | 12 | $256 |
| Allopurinol | 32 | $235 |
| Clindamycin Hcl | 28 | $212 |
| Methylprednisolone | 19 | $135 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Las Vegas
- Troy WatsonLas Vegas$1.2M
- Ira WeinerLas Vegas$135K
- Abdolreza RaissiLas Vegas$110K
- Anthony BorgiaLas Vegas$47K
- Nahad WasselLas Vegas$24K
- Casey BurchillLas Vegas$20K
- Timothy BrookesLas Vegas$14K
- Daniel HallmanLas Vegas$12K
- Thomman KuruvillaLas Vegas$9K
- Blair HendershotLas Vegas$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.